Evidence map›Paper›PMID 40791837›Full record

ArticleIranian journal of otorhinolaryngology2025

Rhinophyma Treatment with Blue Laser.

Estefanía Miranda, Ithzel-María Villarreal, Oscar Arenas, Guillermo Plaza

Abstract readCase Reports
In one paragraph

Article in Iranian journal of otorhinolaryngology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Estefanía MirandaDepartment of Otorhinolaryngology Head and Neck Surgery, Faculty of Medicine, Hospital Universitario de Fuenlabrada, Universidad Rey Juan Carlos. Madrid, Spain.
Ithzel-María VillarrealDepartment of Otorhinolaryngology Head and Neck Surgery, Faculty of Medicine, Hospital Universitario de Fuenlabrada, Universidad Rey Juan Carlos. Madrid, Spain.
Oscar ArenasDepartment of Otorhinolaryngology Head and Neck Surgery, Faculty of Medicine, Hospital Universitario de Fuenlabrada, Universidad Rey Juan Carlos. Madrid, Spain.
Guillermo PlazaDepartment of Otorhinolaryngology Head and Neck Surgery, Faculty of Medicine, Hospital Universitario de Fuenlabrada, Universidad Rey Juan Carlos. Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Rhinophyma is a chronic skin pathology that mainly affects the nose. It is featured by thickening of the skin and soft tissue of the nose. Treatment options include topical medication, systemic drugs, electrocautery, cryosurgery, laser therapy, dermabrasion, and in some cases, surgical procedures like rhinoplasty. The aim of this report is to demonstrate the usefulness of the blue laser and its efficacy in the treatment of rhinophyma. Case Report: We report two cases of patients diagnosed with rhinophyma who underwent blue laser treatment. Conclusions: The use of blue laser to treat rhinophyma has shown to be an effective and safe procedure with very promising results.

Indexed as

Blue laserlaser therapyRhinophymaRosacea

Identifiers

PMID40791837
PMCPMC12335665

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.